Frank C Brosius1, John Cijiang He. 1. aDepartments of Internal Medicine and Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA bDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract
PURPOSE OF REVIEW: To review the role of Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling in the progression of chronic kidney diseases. RECENT FINDINGS: The JAK-STAT pathway transmits signals from extracellular ligands, including many cytokines and chemokines. While these responses are best characterized in lymphoid cells, they also occur in kidney cells such as podocytes, mesangial cells, and tubular cells. JAK-STAT expression and signaling abnormalities occur in humans and animal models of different chronic kidney diseases. Enhanced expression and augmented activity of JAK1, JAK2, and STAT3 promote diabetic nephropathy and their inhibition appears to reduce the disease. Activation of JAK-STAT signaling in autosomal dominant polycystic kidney disease may play an important role in cyst growth. Activation of JAK-STAT signaling promotes HIV-associated nephropathy and may also participate in the tubular responses to chronic obstructive uropathy. On the basis of data from experimental models, inhibition of JAK-STAT signaling, via increased expression of the suppressors of cytokine signaling proteins or pharmacologic inhibition of JAK and STAT proteins, could play a therapeutic role in multiple chronic kidney diseases. SUMMARY: Activation of the JAK-STAT pathway appears to play a role in the progression of some chronic kidney diseases. More work is needed to determine the specific role the pathway plays in individual diseases.
PURPOSE OF REVIEW: To review the role of Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling in the progression of chronic kidney diseases. RECENT FINDINGS: The JAK-STAT pathway transmits signals from extracellular ligands, including many cytokines and chemokines. While these responses are best characterized in lymphoid cells, they also occur in kidney cells such as podocytes, mesangial cells, and tubular cells. JAK-STAT expression and signaling abnormalities occur in humans and animal models of different chronic kidney diseases. Enhanced expression and augmented activity of JAK1, JAK2, and STAT3 promote diabetic nephropathy and their inhibition appears to reduce the disease. Activation of JAK-STAT signaling in autosomal dominant polycystic kidney disease may play an important role in cyst growth. Activation of JAK-STAT signaling promotes HIV-associated nephropathy and may also participate in the tubular responses to chronic obstructive uropathy. On the basis of data from experimental models, inhibition of JAK-STAT signaling, via increased expression of the suppressors of cytokine signaling proteins or pharmacologic inhibition of JAK and STAT proteins, could play a therapeutic role in multiple chronic kidney diseases. SUMMARY: Activation of the JAK-STAT pathway appears to play a role in the progression of some chronic kidney diseases. More work is needed to determine the specific role the pathway plays in individual diseases.
Authors: Wouter N Leonhard; Annemieke van der Wal; Zlata Novalic; Steven J Kunnen; Ron T Gansevoort; Martijn H Breuning; Emile de Heer; Dorien J M Peters Journal: Am J Physiol Renal Physiol Date: 2011-02-23
Authors: M B Marrero; B Schieffer; W G Paxton; L Heerdt; B C Berk; P Delafontaine; K E Bernstein Journal: Nature Date: 1995-05-18 Impact factor: 49.962
Authors: Guadalupe Ortiz-Muñoz; Virginia Lopez-Parra; Oscar Lopez-Franco; Paula Fernandez-Vizarra; Beñat Mallavia; Claudio Flores; Ana Sanz; Julia Blanco; Sergio Mezzano; Alberto Ortiz; Jesus Egido; Carmen Gomez-Guerrero Journal: J Am Soc Nephrol Date: 2010-02-25 Impact factor: 10.121
Authors: Srdan Verstovsek; Hagop Kantarjian; Ruben A Mesa; Animesh D Pardanani; Jorge Cortes-Franco; Deborah A Thomas; Zeev Estrov; Jordan S Fridman; Edward C Bradley; Susan Erickson-Viitanen; Kris Vaddi; Richard Levy; Ayalew Tefferi Journal: N Engl J Med Date: 2010-09-16 Impact factor: 91.245
Authors: Lavinia Paternoster; Marie Standl; Chih-Mei Chen; Adaikalavan Ramasamy; Klaus Bønnelykke; Liesbeth Duijts; Manuel A Ferreira; Alexessander Couto Alves; Jacob P Thyssen; Eva Albrecht; Hansjörg Baurecht; Bjarke Feenstra; Patrick M A Sleiman; Pirro Hysi; Nicole M Warrington; Ivan Curjuric; Ronny Myhre; John A Curtin; Maria M Groen-Blokhuis; Marjan Kerkhof; Annika Sääf; Andre Franke; David Ellinghaus; Regina Fölster-Holst; Emmanouil Dermitzakis; Stephen B Montgomery; Holger Prokisch; Katharina Heim; Anna-Liisa Hartikainen; Anneli Pouta; Juha Pekkanen; Alexandra I F Blakemore; Jessica L Buxton; Marika Kaakinen; David L Duffy; Pamela A Madden; Andrew C Heath; Grant W Montgomery; Philip J Thompson; Melanie C Matheson; Peter Le Souëf; Beate St Pourcain; George Davey Smith; John Henderson; John P Kemp; Nicholas J Timpson; Panos Deloukas; Susan M Ring; H-Erich Wichmann; Martina Müller-Nurasyid; Natalija Novak; Norman Klopp; Elke Rodríguez; Wendy McArdle; Allan Linneberg; Torkil Menné; Ellen A Nohr; Albert Hofman; André G Uitterlinden; Cornélia M van Duijn; Fernando Rivadeneira; Johan C de Jongste; Ralf J P van der Valk; Matthias Wjst; Rain Jogi; Frank Geller; Heather A Boyd; Jeffrey C Murray; Cecilia Kim; Frank Mentch; Michael March; Massimo Mangino; Tim D Spector; Veronique Bataille; Craig E Pennell; Patrick G Holt; Peter Sly; Carla M T Tiesler; Elisabeth Thiering; Thomas Illig; Medea Imboden; Wenche Nystad; Angela Simpson; Jouke-Jan Hottenga; Dirkje Postma; Gerard H Koppelman; Henriette A Smit; Cilla Söderhäll; Bo Chawes; Eskil Kreiner-Møller; Hans Bisgaard; Erik Melén; Dorret I Boomsma; Adnan Custovic; Bo Jacobsson; Nicole M Probst-Hensch; Lyle J Palmer; Daniel Glass; Hakon Hakonarson; Mads Melbye; Deborah L Jarvis; Vincent W V Jaddoe; Christian Gieger; David P Strachan; Nicholas G Martin; Marjo-Riitta Jarvelin; Joachim Heinrich; David M Evans; Stephan Weidinger Journal: Nat Genet Date: 2011-12-25 Impact factor: 38.330
Authors: Tamadher A Alghamdi; Syamantak Majumder; Karina Thieme; Sri N Batchu; Kathryn E White; Youan Liu; Angela S Brijmohan; Bridgit B Bowskill; Suzanne L Advani; Minna Woo; Andrew Advani Journal: J Am Soc Nephrol Date: 2017-04-19 Impact factor: 10.121
Authors: Patrick M McLendon; Gregory Davis; James Gulick; Sonia R Singh; Na Xu; Nathan Salomonis; Jeffery D Molkentin; Jeffrey Robbins Journal: Circ Res Date: 2017-06-27 Impact factor: 17.367